Scholars Central

EditorialPublished 28 Jun 2024

Clinical Pharmacokinetics of Novel Biopharmaceuticals

Authors: Kudirat Taofeek Tope

Future of Medicine, Science, Technology and Innovation Research Group, School of Medicine and, Pharmacy, University of Rwanda, Rwanda

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 6 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biopharmaceuticals, including monoclonal antibodies, fusion proteins, and therapeutic peptides, have emerged as pivotal therapies in modern medicine due to their targeted efficacy and reduced side effects compared to traditional drugs. Understanding their clinical pharmacokinetics is crucial for optimizing therapeutic outcomes and ensuring patient safety. This review explores the absorption, distribution, metabolism, and excretion (ADME) of novel biopharmaceuticals, highlighting factors influencing their pharmacokinetic profiles and clinical implications. Insights into biopharmaceutical pharmacokinetics inform dosing strategies, therapeutic monitoring, and the development of personalized medicine approaches

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Kudirat Taofeek Tope”